← boothcheck

Is OHI overvalued?

boothcheck doesn't label OHI overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, OHI is priced for growth of -3.0%. Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium). The more the price assumes beyond what OMEGA HEALTHCARE INVESTORS, INC. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from OMEGA HEALTHCARE INVESTORS, INC.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth-3.0%
For about
Margin needed
Margin today
Price vs asset value1.94x
Price vs earnings power1.86x
Price vs peer multiples1.52x
Price vs forward growth0.92x
Read the full OHI report →
Get boothcheck's read on what OHI's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.